维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="AKITA RW"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Preclinical studies with erlotinib (Tarreva) 显示文摘	Akita RW Sliwkowski MX	2003	Semin Oncol2003，30，37：	1
2	Identifica- tion of neuregulin, a specific activator of p185erbB2 显示文摘	Holmes WE Sliwkowski MX Akita RW	1992	Science1992，256，：	1
3	Ligand - independent HER2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC - 0941 显示文摘	Junttila TT Akita RW Parsons K	2009	Cancer Cell2009，15，5：	1
4	Preclinical studies with erlotinib (TarcevaTM) 显示文摘	Akita RW Sliwkowaki MX	2003	Semin Oncol2003，30，37：	1
5	Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941显示文摘	Junttila TT Akita RW Parsons K	2009	Cancer Cell2009，15，5：	1
6	Ligand-independent Her-2/ HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-O941显示文摘	Junttila TT Akita RW Parsons K		0，，05：	1
7	Preclinical studies with erlotinib(TarcevaTM)显示文摘	AKITA RW SLIWKOWSKI MX	2003	Semin Oncol2003，30，37：	1
8	Targeting ligand-actibated ErbB2 singaling inhibits breast and prostate tumor growth 显示文摘	Agus DB Akita RW Fox WD	2002	Cancer Cell2002，2，2：	1
9	Binding specificities and affinities of egf domains for ErbB receptors显示文摘	Jones JT Akita RW Sliwkowski MX	1999	FEBS Lett1999，447，23：	1
10	Ligand-independent Her-2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941显示文摘	Junttila TT Akita RW Parsons K	2000	Cancer Cell2000，15，5：	1
11	Identification of heregulin,a specific activator of p185erb B2显示文摘	Holmes WE Sliwkowski MX Akita RW	1992	Science1992，256，5060：	1
12	Identification of heregulin,a specific activator of p185erbB2显示文摘	Holmes WE Sliwkowski MX Akita RW	1992	Science1992，256，5060：	1
13	Identification of Heregulin, a specific activator of p185erbB2 显示文摘	Holmes WE Sliwkowski MX Akita RW	1992	Science1992，256，5060：	1
14	Binding specificities and affinities of egf domains for ErbB receptors显示文摘	Jones JT Akita RW Sliwkowski MX	1999	FEBS Lett1999，447，：	1
15	Ligand - inde- pendent Her -2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhib- itor GDC - 0941 显示文摘	Junttila tiT Akita RW Parsons K	2009	Cancer Cell2009，15，5：	1
16	Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth显示文摘	Agus DB Akita RW Fox WD	2002	Cancer Cell2002，2，2：	1
17	Targeting ligand - ac- tivated ErbB - 2 signaling inhibits breast and prostate tumor growth 显示文摘	Agus DB Akita RW Fox WD	2002	Cancer Cell2002，2，：	1
18	Targeting ligandactivated ErbB2 signaling inhibits breast and prostate tumor growth显示文摘	AGUS DB AKITA RW FOX WD	2002	Cancer Cell2002，2，2：	1
19	Identification of heregulin,a specific activator of p185erb B2显示文摘	Holmes WE Sliwkowski MX Akita RW	1992	Science1992，256，：	1
20	Ligand - inde- pendent HER2/HER3/PI3K complex is disrupted by tras- tuzumab and is effectively inhibited by the PI3K inhibitor GDC - 0941 显示文摘	Junttila TI' Akita RW Parsons K	2009	Cancer Cell2009，15，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示